OCM™ is a first-in-class, HCP-administered drug-device that delivers complete and personalized
therapy targeting every phase of wound healing.
It’s engineered to reduce biofilm impact,
decrease inflammation, enhance proliferation, and support tissue remodeling.
See IFU for full indications and precautions.
OCM™ is developed using a proprietary process that forms an amorphous solid, conforming to the wound bed—including tunnels and irregular surfaces. This flexible sheet supports comprehensive wound healing by combining a first-in-class formulation with multimodal mechanisms of action.
HCPCS Code: A2014
